| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |